Back to Results
First PageMeta Content
Amgen / Pharmacology / Denosumab / Osteoporosis / Endocrinology / Pharmaceutical drug / Osteonecrosis of the jaw / Rheumatology / Medicine / Anatomy / Health


Initial REMS Approval: [removed]Most Recent Modification: [removed]Amgen Inc.
Add to Reading List

Open Document

File Size: 42,77 KB

Share Result on Facebook

City

Reference / /

Company

Amgen Inc. / /

Facility

American College of Rheumatology / American College of Physicians / /

IndustryTerm

treatment for patients with prostate or breast cancer / healthcare providers / communication plan / /

MedicalCondition

osteonecrosis / osteoporosis / hypocalcemia / serious infections / breast cancer / /

Organization

FDA / American Society of Bone Mineral Research / American College of Rheumatology / National Osteoporosis Foundation / American Academy of Family Physicians / Endocrine Society / American Society of Clinical Oncology / American Association of Clinical Endocrinologists / /

/

Product

Prolia Medication / /

ProvinceOrState

California / /

PublishedMedium

the Prolia Medication Guide / The Medication Guide / /

URL

www.proliahcp.com / /

SocialTag